These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38477667)

  • 1. The antiemetic actions of GIP receptor agonism.
    Borner T; De Jonghe BC; Hayes MR
    Am J Physiol Endocrinol Metab; 2024 Apr; 326(4):E528-E536. PubMed ID: 38477667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GIP receptor agonism blocks chemotherapy-induced nausea and vomiting.
    Borner T; Reiner BC; Crist RC; Furst CD; Doebley SA; Halas JG; Ai M; Samms RJ; De Jonghe BC; Hayes MR
    Mol Metab; 2023 Jul; 73():101743. PubMed ID: 37245848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
    Fonte C; Fatigoni S; Roila F
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
    Rizk AN; Hesketh PJ
    Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myths of antiemetic administration.
    Peters CA
    Cancer Nurs; 1989 Apr; 12(2):102-6. PubMed ID: 2713833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Opin Drug Saf; 2016; 15(3):343-56. PubMed ID: 26699406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Options in the treatment of chemotherapy-induced emesis.
    Pendergrass KB
    Cancer Pract; 1998; 6(5):276-81. PubMed ID: 9767346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chemotherapy-induced nausea and vomiting.
    Inrhaoun H; Kullmann T; Elghissassi I; Mrabti H; Errihani H
    J Gastrointest Cancer; 2012 Dec; 43(4):541-6. PubMed ID: 22733566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nausea and vomiting].
    Fujii M
    Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.
    Phillips RS; Friend AJ; Gibson F; Houghton E; Gopaul S; Craig JV; Pizer B
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007786. PubMed ID: 26836199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT.
    Robson S; McParlin C; Mossop H; Lie M; Fernandez-Garcia C; Howel D; Graham R; Ternent L; Steel A; Goudie N; Nadeem A; Phillipson J; Shehmar M; Simpson N; Tuffnell D; Campbell I; Williams R; O'Hara ME; McColl E; Nelson-Piercy C
    Health Technol Assess; 2021 Nov; 25(63):1-116. PubMed ID: 34782054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control.
    Schnell FM
    Oncologist; 2003; 8(2):187-98. PubMed ID: 12697943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Morrow GR; Hickok JT; Rosenthal SN
    Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Yarker YE; McTavish D
    Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of chemotherapy-induced nausea and vomiting.
    Gralla RJ; Tyson LB; Kris MG; Clark RA
    Med Clin North Am; 1987 Mar; 71(2):289-301. PubMed ID: 3546981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.